Effectiveness of Seasonal Malaria Chemoprevention in Nampula Province, Mozambique: Type Two Hybrid Implementation Study

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

3,156

Participants

Timeline

Start Date

January 8, 2022

Primary Completion Date

June 21, 2022

Study Completion Date

December 1, 2023

Conditions
Malaria
Interventions
DRUG

Chemopreventive Agent - SPAQ

Seasonal malaria chemoprevention (SMC) is a highly effective community-based intervention to prevent malaria infections in areas where the malaria burden is high and transmission occurs mainly during the rainy season. It involves administering monthly courses of sulfadoxine-pyrimethamine (SP) and amodiaquine (AQ) during this peak transmission period to those most at risk: children 3-59 months.

DRUG

Control Test - no drugs given

This is where children aged 3-59 months do not receive any chemoprevention drugs but do receive health promotion messages and visit from health workers similar to the chemoprevention SPAQ arm.

Trial Locations (2)

Unknown

Lalaua district, Nampula

Muecate District, Nampula

All Listed Sponsors
lead

Malaria Consortium

OTHER

NCT05186363 - Effectiveness of Seasonal Malaria Chemoprevention in Nampula Province, Mozambique: Type Two Hybrid Implementation Study | Biotech Hunter | Biotech Hunter